Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Ong

Showing results (1-10 of 117) with videos related to

Pageof 12
Sort By:
Current Opinion in Supportive and Palliative Care|July 8, 2011
Recent advances in second-line treatment of castration-resistant prostate cancerMichael Ong, Eric Winquist
Nature Reviews. Urology|January 9, 2020
Evolution in upfront treatment strategies for metastatic RCCDominick Bossé, Michael Ong
Singapore Medical Journal|February 6, 2003
Medical support for the North East Line Mass Rapid Transit project by the Republic of Singapore Navy's Naval Medicine Hyperbaric CentreMichael Ong C C
Annual Review of Public Health|January 16, 2007
Rationale and public health implications of changing CHD risk factor definitionsRobert M Kaplan, Michael Ong
Currents in Pharmacy Teaching & Learning|November 19, 2025
Integrating neurotransmitter-based organization and case-based checkpoints in CNS pharmacotherapy: An innovative teaching approachMohammed F Salahuddin, Michael Ong
Journal of the American Academy of Dermatology|March 18, 2024
Response to Desai et al, "Response to 'Low-dose oral minoxidil for androgenetic alopecia is not associated with clinically significant blood-pressure changes: a retrospective study'"Michael Ong, Shari R Lipner
The Canadian Journal of Cardiology|July 2, 2018
Immune Checkpoint Inhibitors: Game Changing Cancer Therapy With a Cardiac Cost. What Are the Mechanisms and Unresolved Questions in Cardiotoxicity?Christopher B Johnson, Michael Ong
Clinical Therapeutics|June 18, 2003
A time-series analysis of the effect of increased copayments on the prescription of antidepressants, anxiolytics, and sedatives in Sweden from 1990 to 1999Michael Ong, Ralph Catalano, Terry Hartig
European Urology Focus|June 23, 2026
How will PLUDO, PSMAfore, SPLASH, and ECLIPSE Impact Prostate Cancer Management?Jean-Mathieu Beauregard, Michael Ong, Frédéric Pouliot
Pediatric Emergency Care|August 17, 2006
Unscheduled return visits to the pediatric emergency department-one-year experienceRan D Goldman, Michael Ong, Alison Macpherson
Pageof 12

Showing results (1-10 of 117) with videos related to

Sort By:
Pageof 12
Current Opinion in Supportive and Palliative Care|July 8, 2011
Recent advances in second-line treatment of castration-resistant prostate cancerMichael Ong, Eric Winquist
Nature Reviews. Urology|January 9, 2020
Evolution in upfront treatment strategies for metastatic RCCDominick Bossé, Michael Ong
Singapore Medical Journal|February 6, 2003
Medical support for the North East Line Mass Rapid Transit project by the Republic of Singapore Navy's Naval Medicine Hyperbaric CentreMichael Ong C C
Annual Review of Public Health|January 16, 2007
Rationale and public health implications of changing CHD risk factor definitionsRobert M Kaplan, Michael Ong
Currents in Pharmacy Teaching & Learning|November 19, 2025
Integrating neurotransmitter-based organization and case-based checkpoints in CNS pharmacotherapy: An innovative teaching approachMohammed F Salahuddin, Michael Ong
Journal of the American Academy of Dermatology|March 18, 2024
Response to Desai et al, "Response to 'Low-dose oral minoxidil for androgenetic alopecia is not associated with clinically significant blood-pressure changes: a retrospective study'"Michael Ong, Shari R Lipner
The Canadian Journal of Cardiology|July 2, 2018
Immune Checkpoint Inhibitors: Game Changing Cancer Therapy With a Cardiac Cost. What Are the Mechanisms and Unresolved Questions in Cardiotoxicity?Christopher B Johnson, Michael Ong
Clinical Therapeutics|June 18, 2003
A time-series analysis of the effect of increased copayments on the prescription of antidepressants, anxiolytics, and sedatives in Sweden from 1990 to 1999Michael Ong, Ralph Catalano, Terry Hartig
European Urology Focus|June 23, 2026
How will PLUDO, PSMAfore, SPLASH, and ECLIPSE Impact Prostate Cancer Management?Jean-Mathieu Beauregard, Michael Ong, Frédéric Pouliot
Pediatric Emergency Care|August 17, 2006
Unscheduled return visits to the pediatric emergency department-one-year experienceRan D Goldman, Michael Ong, Alison Macpherson
Pageof 12